| BCBS Premera WA AK Clinical | Medical Necessity Criteria for Pharmacy Edits | 2025-03-24 |
| BCBS Premera WA AK Clinical | 5.01.527 Ampyra (Dalfampridine) | 2025-03-24 |
| BCBS Premera WA AK Clinical | Increlex (mecasermin); Recombinant Human Insulin-Like | 2025-03-24 |
| BCBS Premera WA AK Clinical | mTOR Kinase Inhibitors | 2025-03-24 |
| BCBS Premera WA AK Clinical | Injectable Clostridial Collagenase for Fibroproliferative | 2025-03-24 |
| BCBS Premera WA AK Clinical | Pharmacologic Treatment in Assisted Reproduction | 2025-03-24 |
| BCBS Premera WA AK Clinical | Cutaneous T-Cell Lymphomas (CTCL): Systemic Therapies | 2025-03-24 |
| BCBS Premera WA AK Clinical | 5.01.637 Pharmacologic Treatment of Alopecia | 2025-03-24 |
| BCBS Premera WA AK Clinical | 10.01.535 High-Risk Conditions (Oral Health) Dental Benefit | 2025-03-24 |
| BCBS Premera WA AK Clinical | 5.01.542 Medical Necessity Criteria for Medication Safety: Controlled... | 2025-03-24 |